Mandadi Tilak bought CVS
March 31, 2026 · Form 4 insider transaction
Mandadi Tilak bought 22,277 shares of CVS Health Corporation at $71.82 per share, a transaction worth $1.60M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,277
Price
$71.82
Total value
$1.60M
InsiderMandadi Tilak
Role—
CompanyCVS Health Corporation (CVS)
SecurityCommon Stock (RSUs)
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after88,543
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.